Fisher & Paykel Healthcare Target Price Raised by UBS
Fisher & Paykel Healthcare Target Price Raised
UBS has raised its target price for Fisher & Paykel Healthcare (FPH.NZ) by 0.5% to NZ$37.50 per share. The decision is based on the company's strong performance and growth potential.
Analyst View
UBS analysts expect the company to maintain its leading position in respiratory devices and patient care products. The target price revision reflects favorable market conditions and increasing demand expectations.
Market Reaction
Following the news, Fisher & Paykel Healthcare shares saw a slight uptick. Investors are closely monitoring the company's financial results in the coming quarters.
Impacted Symbols
Symbols affected by this headline and their sentiment signals
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.